DÉRIVÉS DE CHROMÈNE UTILISÉS COMME INHIBITEURS DE L'INTERACTION TCR-NCK

• 收藏
• 分享

专利权人:

Artax Biopharma Inc.

发明人:

申请号：

EP14806053.6

公开号：

EP3059231A1

申请日:

2014.10.20

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The present invention relates to a group of compounds of formula (I) containing a chromene nucleus:and which present the ability to inhibit the lymphocytes proliferation mediated by the TCR interaction with Nck, so that the present invention also relates to the use of these compounds for the treatment of diseases or conditions wherein said interaction triggers a complication such as transplant rejection reactions, immune or autoimmune diseases, inflammatory diseases or proliferative diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/